Obesity directly affects kidney health and influences chronic kidney disease (CKD) risk and progression through contributing ...

About 40% of hormone-positive breast cancers in postmenopausal women might be linked to excess body fat, researchers reported ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Weight-loss jabs are “not the holy grail”, the NHS medical director has said ...

A group of health professionals have called for a review of obesity management services in light of increased public demand ...

Weight loss jabs are not a “holy grail” and will not solve the obesity crisis on their own, England’s top doctor has said.

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Michele Schneider, chief strategist at MarketGauge, says the rise in popularity of obesity drugs are boosting a new realm of ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

Earlier this year, J.P. Morgan released a report outlining the potential for GLP-1 treatments in other markets. Specifically, ...

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?